Picture of Cytek Biosciences logo

CTKB — Cytek Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Cytek Biosciences Reports Fourth Quarter And Full Year 2022 Financial Results

Feb 28 (Reuters) - Cytek Biosciences Inc  CTKB.O :
    * CYTEK BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS
    * TOTAL REVENUE WAS $48.3 MILLION, OR $51.2 MILLION ON A
CONSTANT
CURRENCY BASIS, FOR Q4 OF 2022
    * EXPECTS FULL YEAR 2023 REVENUE IN RANGE OF $225 MILLION TO
$235
MILLION
    * Q4 REVENUE VIEW $50.2 MILLION -- REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $214.7 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX2ZWmNx 
Further company coverage:  CTKB.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Cytek Biosciences

See all news